UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
Novavax unveiled the successful results of the phase-1 clinical trial on a ...
by Kim Yun-mi
|
2020-09-03 14:50
라인
‘Cyramza helped improve gastric cancer treatment in Korea’
Lilly’s Cyramza (ingredient: ramucirumab), an inhibitor of vascular endothe...
by Kim Yun-mi
|
2020-09-03 14:49
라인
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
The European Society of Cardiology recently announced the 2020 ESC guidelin...
by Kim Yun-mi
|
2020-09-02 16:33
라인
AZ requests court to nullify Dong-A ST’s avoidance of Forxiga patent
AstraZeneca filed a suit with the Patent Court to cancel the Intellectual P...
by Kim Yun-mi
|
2020-09-01 15:40
라인
Doctors force drug sales reps to support ongoing strike
Physicians are asking pharmaceutical sales representatives to criticize the...
by Kim Yun-mi
|
2020-09-01 11:24
라인
‘Korea should introduce indication-specific drug pricing’
“Korea must introduce a system to apply different prices for a drug’s multi...
by Kim Yun-mi
|
2020-08-31 15:28
라인
Korea publishes guidelines for digital therapeutics
The Ministry of Food and Drug Safety has published the guidelines for winni...
by Kim Yun-mi
|
2020-08-27 18:05
라인
Drugmakers to sue government for limiting choline alfoscerate benefit
Manufacturers of choline alfoscerate, a dementia drug, are reportedly prepa...
by Kim Yun-mi
|
2020-08-27 14:26
라인
Novartis fails trial on skin cancer drug candidate spartalizumab
Novartis said it its phase-3 trial on immunotherapy spartalizumab, a progra...
by Kim Yun-mi
|
2020-08-26 11:11
라인
Drug sales reps refrain from visiting doctors amid Covid-19 resurge
An increasing number of pharmaceutical companies are holding the activities...
by Kim Yun-mi
|
2020-08-21 16:00
라인
‘Metastatic pancreatic cancer needs insurance benefit for Onyvide+5-FU/LV’
Patients with metastatic pancreatic cancer, notorious for high fatality, ne...
by Kim Yun-mi
|
2020-08-21 15:21
라인
MSD Korea’s spinoff Organon Korea to settle in Gwanghwamun
Organon Korea, a spinoff from MSD Korea, will use a shared office in Gwangh...
by Kim Yun-mi
|
2020-08-18 11:39
라인
‘NSAIDs after myocardial infarction raise bleeding risk’
Using nonsteroidal anti-inflammatory drugs (NSAIDs) with antiplatelet agent...
by Kim Yun-mi
|
2020-07-28 16:17
라인
AZ’s 3-in-1 inhaler for COPD to compete with GSK’s Trelegy
AstraZeneca’s winning of approval for Breztri Aerosphere (ingredient: budes...
by Kim Yun-mi
|
2020-07-27 15:09
라인
‘Tecentriq plus chemo can double survival in triple-negative breast cancer’
Roche Korea won approval for Tecentriq (ingredient: atezolizumab) in Februa...
by Kim Yun-mi
|
2020-07-24 16:04
라인
Prosecutors raid GSK Korea’s vaccine division
Prosecutors have raided GSK Korea’s vaccine division, an industry source sa...
by Kim Yun-mi
|
2020-07-23 11:04
라인
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
“Before Imfinzi arrived, all physicians could do for a state-3 unresectable...
by Kim Yun-mi
|
2020-07-16 14:37
라인
Biogen, Esai to test another Alzheimer’s drug in phase-3 study
Biogen and Eisai, whose collaboration for experimental Alzheimer’s drug adu...
by Kim Yun-mi
|
2020-07-15 12:42
라인
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’
Gilead Sciences said its Covid-19 drug candidate remdesivir reduced the ris...
by Kim Yun-mi
|
2020-07-13 14:44
라인
Multinational drugmakers seek to form new trade union
Some workers at the Korean offshoots of multinational pharmaceutical compan...
by Kim Yun-mi
|
2020-07-13 11:44
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top